Free Trial
NASDAQ:VMD

Viemed Healthcare (VMD) Stock Price, News & Analysis

Viemed Healthcare logo
$7.05 -0.02 (-0.28%)
As of 02:03 PM Eastern

About Viemed Healthcare Stock (NASDAQ:VMD)

Key Stats

Today's Range
$6.82
$7.08
50-Day Range
$7.07
$8.48
52-Week Range
$6.21
$9.81
Volume
74,344 shs
Average Volume
109,712 shs
Market Capitalization
$278.63 million
P/E Ratio
26.11
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

Remove Ads

Viemed Healthcare Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
21st Percentile Overall Score

VMD MarketRank™: 

Viemed Healthcare scored higher than 21% of companies evaluated by MarketBeat, and ranked 856th out of 927 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Viemed Healthcare is 25.67, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.97.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Viemed Healthcare is 25.67, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 22.85.

  • Price to Book Value per Share Ratio

    Viemed Healthcare has a P/B Ratio of 2.34. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Viemed Healthcare's valuation and earnings.
  • Percentage of Shares Shorted

    0.93% of the float of Viemed Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    Viemed Healthcare has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Viemed Healthcare has recently increased by 10.49%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Viemed Healthcare does not currently pay a dividend.

  • Dividend Growth

    Viemed Healthcare does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.93% of the float of Viemed Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    Viemed Healthcare has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Viemed Healthcare has recently increased by 10.49%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Viemed Healthcare has a news sentiment score of 1.24. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Viemed Healthcare this week, compared to 1 article on an average week.
  • MarketBeat Follows

    1 people have added Viemed Healthcare to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Viemed Healthcare insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    20.00% of the stock of Viemed Healthcare is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    74.24% of the stock of Viemed Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Viemed Healthcare's insider trading history.
Receive VMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Viemed Healthcare and its competitors with MarketBeat's FREE daily newsletter.

VMD Stock News Headlines

Viemed Healthcare, Inc. (VMD): A Bull Case Theory
This almost killed Elon Musk (chilling details emerge)
Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late.
See More Headlines

VMD Stock Analysis - Frequently Asked Questions

Viemed Healthcare's stock was trading at $8.02 at the start of the year. Since then, VMD stock has decreased by 13.6% and is now trading at $6.93.
View the best growth stocks for 2025 here
.

Viemed Healthcare, Inc. (NASDAQ:VMD) issued its quarterly earnings results on Wednesday, November, 6th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.08 by $0.02. The business earned $58 million during the quarter. Viemed Healthcare had a net margin of 4.87% and a trailing twelve-month return on equity of 8.72%.

Viemed Healthcare's top institutional shareholders include Penbrook Management LLC (0.52%). Insiders that own company stock include Nitin Kaushal, Randy E Dobbs, Timothy Smokoff and Sabrina Heltz.
View institutional ownership trends
.

Shares of VMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Viemed Healthcare investors own include Myomo (MYO), Cassava Sciences (SAVA), Alpha Teknova (TKNO), Heron Therapeutics (HRTX), Advanced Micro Devices (AMD), Zevra Therapeutics (ZVRA) and Enterprise Products Partners (EPD).

Company Calendar

Last Earnings
11/06/2024
Today
4/03/2025
Next Earnings (Estimated)
5/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
Healthcare
Current Symbol
NASDAQ:VMD
Fax
N/A
Employees
630
Year Founded
N/A

Profitability

Trailing P/E Ratio
26.11
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$10.24 million
Pretax Margin
6.97%

Debt

Sales & Book Value

Annual Sales
$224.26 million
Cash Flow
$0.74 per share
Price / Cash Flow
9.56
Book Value
$2.96 per share
Price / Book
2.38

Miscellaneous

Free Float
31,150,000
Market Cap
$278.63 million
Optionable
Not Optionable
Beta
1.50
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:VMD) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners